Immune Perturbations After Cardiopulmonary Bypass: A Randomized Trial of Cytokine Adsorption
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817241 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von ZT. Taghiyev und 9 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Cardiopulmonary bypass (CPB) induces profound immune alterations, including lymphopenia and neutrophilia. Hemoadsorption has been proposed as a strategy to mitigate these inflammatory responses; however, its impact on immune cell dynamics remains insufficiently defined.
Methods
In a randomized study, 50 patients scheduled for elective cardiac surgery with CPB were allocated either to a group receiving intraoperative hemoadsorption (Cytosorb-Group, n = 25) or to a control group treated with the standard procedure (Control-Group, n = 25). Blood was collected at baseline (T0), after CPB (T1), 8 hours post-CPB (T2), and 24 hours post-CPB (T3). Leukocyte differentials and flow cytometry were performed. Analyses included within- and between-group comparisons and trajectory modeling.
Results
Both groups displayed the characteristic postoperative immune shift. In the pooled cohort ( n = 50), neutrophils increased from 60% [95% CI: 57–63] at baseline to 76% [73–79] at T2 (Δ + 16%, p 0.1).
Conclusion
CPB induces profound but transient immune perturbations, most evident 8 hours postoperatively. Hemoadsorption was associated with minor differences in selected subsets but did not alter overall immune trajectories. Larger trials are required to determine whether such immunological effects translate into clinical benefit. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Taghiyev, Z., Useini, D., Chapugi, B., Senker, A., Kern, L., Karabacak, E., Arneth, B., Mkhlof, S., Skevaki, C., & Böning, A. (2026). Immune Perturbations After Cardiopulmonary Bypass: A Randomized Trial of Cytokine Adsorption. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817241
Vancouver
Taghiyev Z, Useini D, Chapugi B, Senker A, Kern L, Karabacak E, et al. Immune Perturbations After Cardiopulmonary Bypass: A Randomized Trial of Cytokine Adsorption. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817241
BibTeX
@article{Taghiyev2026,
author = {Taghiyev, ZT. and Useini, D. and Chapugi, B. and Senker, A. and Kern, LC. and Karabacak, EC. and Arneth, B. and Mkhlof, S. and Skevaki, C. and Böning, A.},
title = {Immune Perturbations After Cardiopulmonary Bypass: A Randomized Trial of Cytokine Adsorption},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817241}
}
EUVIMED